Ashwagandha and Sedatives (Benzodiazepines): Interactions

Ashwagandha is one of the most popular adaptogens on the supplement market, marketed mainly for stress reduction and improved sleep quality. The problem is that the same mechanism that makes it effective for those purposes also makes it potentially problematic when combined with drugs that have a similar action profile. A supplement “for stress and sleep” and a drug “for anxiety and sleep” can simply add up in the body.

Withania somnifera contains a group of compounds called withanolides (including withaferin A), along with alkaloids and glycowithanolides, to which most of the plant's documented effects are attributed. Preclinical research indicates that some of these compounds show GABA-mimetic activity — meaning they mimic or enhance the action of gamma-aminobutyric acid (GABA), the brain's main inhibitory neurotransmitter. This is the same neurotransmitter targeted by benzodiazepines, though through a different, more direct receptor mechanism.

The difference matters: benzodiazepines bind directly to a modulatory site on the GABA-A receptor, producing fast, strong sedation, while ashwagandha's effect appears more subtle, indirect, and spread out over time — closer to a gentle dampening of nervous tension than a pharmacological “off switch.” That doesn't change the direction of the effect, though: both mechanisms ultimately boost inhibitory signaling in the central nervous system, and additive effects when used together are biologically expected, not just theoretical.

The strength of this interaction isn't fixed — it depends on several variables worth understanding rather than treating the topic in black and white. Ashwagandha's dose matters: standard supplemental doses (300–600 mg of standardized extract daily) differ meaningfully from the doses used in traditional Ayurvedic practice, which are often higher and less standardized. The specific benzodiazepine and its half-life matter too — long-acting drugs (diazepam, clonazepam) accumulate in the body differently than short-acting ones (lorazepam, alprazolam), which changes how the two effects overlap over the course of a day.

Individual sensitivity to sedation — shaped by age, liver metabolism, body weight, and tolerance built up to the benzodiazepine — further varies the response between people. In older adults, whose drug metabolism is slower and whose sensitivity to sedation is already higher, even a moderate dose of ashwagandha added to stable benzodiazepine therapy can tip the balance toward excessive drowsiness or impaired balance, raising fall risk — a particularly important concern in this age group.

The greatest risk obviously applies to people knowingly combining ashwagandha with a prescribed benzodiazepine, perhaps believing a “natural” supplement will help reinforce the drug's effect on anxiety or insomnia. But that's not the only risk group. An equally important, often overlooked group consists of people who don't tell their doctor about ashwagandha supplementation when starting benzodiazepine therapy — from the prescribing doctor's perspective, the full picture is then missing, making it harder to predict how strongly the patient will respond.

A third group consists of people using ashwagandha alongside other sedating substances independent of benzodiazepines — alcohol, first-generation antihistamines, certain pain medications, or other sleep supplements (melatonin, valerian, high-dose L-theanine). In clinical practice, a clean two-substance combination is rare — usually several overlap at once, which makes it hard to pin excessive sedation on any one specific ingredient.

The best evidence that ashwagandha's sedative effect isn't marginal comes from a randomized clinical trial evaluating its impact on insomnia and anxiety in humans — not just in animal or lab models.

This reasoning — “natural, therefore safe in any combination” — is one of the most common cognitive biases in supplementation, and it isn't unique to ashwagandha. A plant substance's strength doesn't depend on its origin (natural versus synthetic), but on its biological activity — and ashwagandha has documented biological activity on the central nervous system, strong enough to be measured in a randomized clinical trial.

Ashwagandha has deservedly gained popularity as one of the better-studied adaptogens on the market — but precisely because it works, it deserves the same level of attention when combined with medications that we apply to any other pharmacologically active substance. This isn't a reason to panic or give up the supplement, but a reason to talk to a doctor or pharmacist before the combination becomes an everyday routine.